Cited by 93Inflammasome and immune disordersNeuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Inflammasome-mediated innate immunity in Alzheimer’s disease

Open access
Venegas, Carmen, Heneka, Michael T.·2019·The FASEB Journal

Abstract

Historically neurodegenerative diseases, Alzheimer's disease (AD) in particular, have been viewed to be primarily caused and driven by neuronal mechanisms. Very recently, due to experimental, genetic, and epidemiologic evidence, immune mechanisms have entered the central stage and are now believed to contribute significantly to risk, onset, and disease progression of this class of disorders. Although immune activation of microglial cells may over time engage various signal transduction pathways, inflammasome activation, which represents a canonical and initiating pathway, seems to be one of the first responses to extracellular β-amyloid (Aβ) accumulation. Here we review the current understanding of inflammasome activation in AD.-Venegas, C., Heneka, M. T. Inflammasome-mediated innate immunity in Alzheimer's disease.

Integrity signals

Registry

Crossref · 10.1096/fj.201900439

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Venegas, C., & Heneka, M. T.
Affiliations
University of Bonn (DE)
Venue
The FASEB Journal
Publisher
Wiley
Published
2019-11-08
Volume
33
Issue
12
Pages
13075-13084
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2986521180
Cited by
93
References
104
Citations by year
2026: 6 · 2025: 19 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 11 · 2020: 13 · 2019: 1
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
  • DZNE Pub (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
  • Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, inflammasome, innate immunity, microglia, amyloid-beta, neuroinflammation, neurodegeneration, inflammasome activation
MeSH terms
Alzheimer Disease, Animals, Humans, Immunity, Innate, Amyloid beta-Peptides, Microglia, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review